Emergency drug use in a pandemic: Harsh lessons from COVID-19

The scientific and clinical communities have both experienced several harsh lessons on clinical care management and drug development during the COVID-19 pandemic. Here, we discuss several key lessons learned and describe a framework within which our two communities can work together and invest in to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, Gail, Ho, Jessica S.Y., Zacharias, William, Jeyasekharan, Anand D., Marazzi, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452505/
https://www.ncbi.nlm.nih.gov/pubmed/34587491
http://dx.doi.org/10.1016/j.cell.2021.09.025
Descripción
Sumario:The scientific and clinical communities have both experienced several harsh lessons on clinical care management and drug development during the COVID-19 pandemic. Here, we discuss several key lessons learned and describe a framework within which our two communities can work together and invest in to improve future pandemic responses.

Ejemplares similares